a description online at pubmed says
One of the most striking changes during mammal aging is a progressive involution of the thymus, associated with an increase in susceptibility to infections, autoimmune diseases and cancer. In order to delay age-related processes, we have developed mitochondria-targeted antioxidant plastoquinonyl decyltriphenyl phosphonium (SkQ1). Here we report that, at low doses, SkQ1 (250 nmol/kg per day) inhibited age-dependent involution of the thymus in normal (Wistar) and senescence-prone (OXYS) rats. SkQ1 preserved total weight and volume of the organ, the volume of thymic cortex and medulla, the thymic cellularity, and the number of CD3+, CD4+, and CD8+ cells in the thymus. Moreover, SkQ1 was especially effective in senescence-prone rats. Thus SkQ1 slows down age-linked decline of the immune system, explaining prevention by this compound of infection-caused death in rodents, previously described in our group.
The progression of thymus size among people goes from obviously radiographically visible at kids to mostly resorbed at 20th century adults. I have wondered if there is a genetics of having a kid sized thymus to maturity then seeing if those people were particularly immune to diseases. If this actually increases the mass of the human adult thymus then it may reasonably improve the human immune system
I dont see why that causes the longevity thing though. similarly there is actually another drug where the fluid reverses oxidative harm to crystalline proteins n acetyl carnosine fluid also cures cataracts.
http://en.wikipedia....AcetylcarnosineI think its awesome a scientist found a highly effective antioxidant that may also increase the size of the human thymus, reducing the risk of disease. I dont have a clue why it would increase MLS though. yet if does, it does.
It has calming, lazifying effects on young mice which is concerning.SkQ1 treatment
significantly decreased locomotor activity (in 12-15 months old SHR and 129/Sv mice) and exercise tolerance in old (20 months) SHR mice. The treatment with SkQ1 (0,5-50 nmol/kg day) increased parameters of the life span in SHR mice (mean life span, mean life span of the last 10% of survival, median and maximum life span) without significant effect on the life span in 129/Sv and HER-2/neu mice. There was no reliable difference in tumor development in all SkQ1-treated mice strains as compared with the control. The drug considerably inhibited the incidence of age-associated non-tumor pathology in SHR mice. Our data suggest geroprotective activity of SkQ1, and a lack of toxic or carcinogenic activities during long term use.
so: it makes young mice less active, makes old mice avoid exercise, while making them generally weller.
On one mouse kind of three it increased longevity an unstated amount.
Theres a possibility that if it shows longevity effects on SHR mouse tissue cultures, yet none at 129/sv mouse tissue cultures yet shows longevizing effects on human tissue cultures that
it will make people live longer. Perhaps the people who take it for other purposes will describe its effect as a longevity drug.
Noting that is is a nice antioxidant that keeps mice from being dead perhaps it could be an effective food preservative with marvelous disease prevention side effects!